96 related articles for article (PubMed ID: 2354814)
1. New cisplatin schedule in combination with aclarubicin (ACR) with high response rate in recurrent gynecological adenocarcinomas.
Chen JT; Hirai Y; Shimizu Y; Hasumi K; Masubuchi K
Gynecol Oncol; 1990 Jul; 38(1):1-5. PubMed ID: 2354814
[TBL] [Abstract][Full Text] [Related]
2. [CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR].
Chen JT; Hirai Y; Nakayama K; Shimizu Y; Yokosuka K; Teshima H; Hamada T; Fujimoto I; Yamauchi K; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1565-70. PubMed ID: 2584809
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
Chen JT; Hasumi K
Gan To Kagaku Ryoho; 1995 Apr; 22(5):653-7. PubMed ID: 7717717
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer.
Goldberg JM; Piver MS; Hempling RE; Recio FO
Gynecol Oncol; 1996 Dec; 63(3):312-7. PubMed ID: 8946864
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study.
Menczer J; Ben-Baruch G; Rizel S; Brenner H
Eur J Gynaecol Oncol; 1992; 13(4):316-8. PubMed ID: 1516581
[TBL] [Abstract][Full Text] [Related]
7. High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.
Hunter RE; Griffin TW; Stevens S; Roman LD; Bokhari F; Reale FR; Tak WK; Fitzgerald TJ; Dillon MB; Rose PG
Cancer; 1991 Nov; 68(9):1890-4. PubMed ID: 1655227
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of gynecological cancer with cis-platinum].
Mano T; Takeshima N; Nakamura Y; Tomimatsu T; Saito T; Miyake T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2895-9. PubMed ID: 3662545
[TBL] [Abstract][Full Text] [Related]
9. Treatment for recurrent ovarian cancer. A report of 2 cases.
Maxwell AM; Jordaan JP
S Afr Med J; 1987 Feb; 71(3):180. PubMed ID: 3810370
[TBL] [Abstract][Full Text] [Related]
10. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer.
Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F
Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.
Hochster H; Chen TT; Lu JM; Hills D; Sorich J; Escalon J; Ivy P; Liebes L; Muggia F
Gynecol Oncol; 2008 Mar; 108(3):500-4. PubMed ID: 18191187
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
13. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
14. [Improvement in the regimen for combined CDDP and CPT-11 chemotherapy].
Shimizu A; Sugitoh Y; Hasegawa A; Okubo K; Fujihara T; Ishikawa T; Suzuki N; Yoda A; Narabayashi A; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1807-11. PubMed ID: 11086417
[TBL] [Abstract][Full Text] [Related]
15. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Mäenpää J; Kangas L; Grönroos M
Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
[TBL] [Abstract][Full Text] [Related]
16. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
Misawa A; Yasuda M
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
[TBL] [Abstract][Full Text] [Related]
17. [Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
Nishida M; Satoh Y; Nishide K; Tsunoda H; Kubo T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2209-15. PubMed ID: 10635306
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
[TBL] [Abstract][Full Text] [Related]
19. [Ifosfamide, cisplatin, adriamycin combination chemotherapy in gynecologic cancer].
Sawada M; Inagaki M; Hirota Y; Hongo J; Ozaki M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3091-4. PubMed ID: 3674894
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]